Evaluation of cellular immunogenicity of recombinant cytochrome p450 cyp141 protein of Mycobacterium tuberculosis in human and mouse model
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Biologicals
- Vol. 52, 25-29
Abstract
No abstract availableKeywords
Funding Information
- Shahrekord University of Medical Sciences
This publication has 27 references indexed in Scilit:
- Structure, function and drug targeting in Mycobacterium tuberculosis cytochrome P450 systemsArchives of Biochemistry and Biophysics, 2007
- Tuberculosis subunit vaccine design: The conflict of antigenicity and immunogenicityClinical Immunology, 2007
- BCG vaccine: efficacy and indications for vaccination and revaccinationJornal de Pediatria, 2006
- Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)—A novel adjuvant inducing both strong CMI and antibody responsesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2005
- ESAT-6 proteins: protective antigens and virulence factors?Trends in Microbiology, 2004
- Evaluation of T-Cell Responses to Novel RD1- and RD2-EncodedMycobacterium tuberculosisGene Products for Specific Detection of Human Tuberculosis InfectionInfection and Immunity, 2004
- Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6Infection and Immunity, 2001
- ESAT-6 Subunit Vaccination againstMycobacterium tuberculosisInfection and Immunity, 2000
- Comparative Evaluation of Low-Molecular-Mass Proteins fromMycobacterium tuberculosisIdentifies Members of the ESAT-6 Family as Immunodominant T-Cell AntigensInfection and Immunity, 2000
- Differential T cell responses toMycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donorsEuropean Journal of Immunology, 1998